Newest Evidence to Thwart the Impact of Hepatitis C– Assess the prevalence, risk factors, newest screening recommendations and practice guidelines for hepatitis C.
Summarize recent pivotal research results related to efficacy and safety of pharmacologic agents for the treatment of hepatitis C, with a focus on triple therapy paradigms.
Evaluate methods for appropriate monitoring and management of patient response to therapy.
Assess the potential role of emerging therapy in the evolving treatment paradigm.
1.25 Free CEUs for Nurse Practitioners which includes 0.5 Hours of Pharmacology
This course also offers Free CEUs for Physicians, PAs, Pharamacists, and Nurses